Company name
2022Founder
LEAH Labs develops investigational immune-cell therapies for cancer in pet dogs, combining gene editing and protein engineering with research across veterinary and human oncology. Its canine CAR-T research includes a clinical trial for dogs with B-cell lymphoma at partner veterinary institutions. The company uses its GeneWeld gene-editing approach to engineer immune cells for this research.